| UHC Commercial Medical & Drug | Electric Tumor Treatment Field Therapy – Commercial and Individual Exchange Medical Policy | 2026-09-01 |
| UHC Commercial Medical & Drug | Genetic Testing for Cardiac Disease – Commercial and Individual Exchange Medical Policy | 2026-09-01 |
| UHC Commercial Medical & Drug | Genetic Testing for Neurological Disorders – Commercial and Individual Exchange Medical Policy | 2026-09-01 |
| UHC Commercial Medical & Drug | Glaucoma Surgical Treatments – Commercial and Individual Exchange Medical Policy | 2026-09-01 |
| UHC Commercial Medical & Drug | Inhaled Nitric Oxide Therapy – Commercial and Individual Exchange Medical Policy | 2026-09-01 |
| UHC Commercial Medical & Drug | Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Scan – Site of Service – Commercial and Individual Exchange Medical Policy | 2026-09-01 |
| UHC Commercial Medical & Drug | Outpatient Cardiology Procedures for EviCore Arrangement (for Oxford Only) – Oxford Medical Policy | 2026-09-01 |
| UHC Commercial Medical & Drug | Outpatient Radiology Procedures for EviCore Arrangement (for Oxford Only) – Oxford Medical Policy | 2026-09-01 |
| UHC Commercial Medical & Drug | Spinal Fusion and Decompression – Commercial and Individual Exchange Medical Policy | 2026-09-01 |
| UHC Commercial Medical & Drug | Spinraza® (Nusinersen) – Commercial Medical Benefit Drug Policy | 2026-09-01 |